Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
This report contains market size and forecasts of Non-Opioid Pain Treatment in Global, including the following market information:
Global Non-Opioid Pain Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Opioid Pain Treatment market was valued at 20110 million in 2021 and is projected to reach US$ 54590 million by 2028, at a CAGR of 15.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medical Cannabis Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Opioid Pain Treatment include Allergan PLC, Canopy Growth, Medical Marijuana Inc., Panag Pharma Inc., Tilray, Aphria Inc., Bedrocan, Cara Therapeutics and Centrexion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Opioid Pain Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Opioid Pain Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Opioid Pain Treatment Market Segment Percentages, by Type, 2021 (%)
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins
Global Non-Opioid Pain Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-Opioid Pain Treatment Market Segment Percentages, by Application, 2021 (%)
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
Global Non-Opioid Pain Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-Opioid Pain Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Opioid Pain Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Opioid Pain Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC